首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1547681

全球腸外營養市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Parenteral Nutrition Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球腸外營養市場需求預計將從 2023 年的 76.1 億美元達到 2032 年近 134.1 億美元的市場規模，2024-2032 年研究期間複合年成長率為 6.49%。

當患者的消化系統無法從食物中吸收營養時，腸外營養將必需的營養直接輸送到血液中。這些營養液透過靜脈注射，含有均衡的碳水化合物、蛋白質、脂肪、維生素和礦物質，以滿足患者的營養需求。這種特殊形式的營養支持通常用於重症監護環境中，治療嚴重營養不良、胃腸道疾病或接受重大手術的患者。

市場動態

推動腸外營養市場的因素包括慢性病發病率的上升、刺激了多種外科手術以及全球老年人口的不斷擴大。腸外營養對於控制重症患者的營養不良、支持手術復原和維持健康至關重要。此外，醫療技術和配方的進步促進了專門解決方案的創建，旨在滿足特定患者群體的營養需求，例如早產兒、癌症患者和胃腸道疾病患者。此外，這種營養品在家庭醫療保健環境和門診護理中的廣泛應用進一步推動了市場成長。此外，醫院和醫療機構擴大採用全腸外營養（TPN）和周邊腸外營養（PPN）以及醫療保健支出和報銷政策的增加有助於市場的擴張。然而，監管限制和有限的報銷選擇可能會阻礙未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球腸外營養市場的每個細分市場進行了包容性評估。腸外營養產業的成長和趨勢為本研究提供了整體方法。

市場區隔

腸外營養市場報告的這一部分提供了有關國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

依營養素

碳水化合物
腸外脂質乳劑
單劑量氨基酸溶液
微量元素
維生素和礦物質

按階段

成人
兒科

按指示

阿茲海默症
營養缺乏
癌症護理
糖尿病
慢性腎臟病
孤兒病
吞嚥困難
疼痛管理
吸收不良/胃腸道疾病/腹瀉
其他

按銷售管道

網上銷售
零售銷售
機構銷售

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲腸外營養市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。腸外營養市場的主要參與者包括百特、Grifols、SA、艾爾建、大塚製藥廠有限公司、阿特維斯公司、B. Braun Melsungen AG、Fresenius Kabi AG、Vifor Pharma、四川科倫製藥有限公司、輝瑞公司（霍升瑞公司）。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 依營養成分進行市場吸引力分析
- 分階段市場吸引力分析
- 按指標進行的市場吸引力分析
- 按銷售管道分類的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球腸外營養市場分析：依營養素分類

按營養素概述
歷史和預測數據
按營養素分析
碳水化合物
腸外脂質乳劑
單劑量氨基酸溶液
微量元素
維生素和礦物質

第 6 章：全球腸外營養市場分析：依階段

按階段概述
歷史和預測數據
階段分析
成人
兒科

第 7 章：全球腸外營養市場分析：按跡象分類

按指示概述
歷史和預測數據
按指標分析
阿茲海默症
營養缺乏
癌症護理
糖尿病
慢性腎臟病
孤兒病
吞嚥困難
疼痛管理
吸收不良/胃腸道疾病/腹瀉
其他

第 8 章：全球腸外營養市場分析：依銷售管道

銷售通路概覽
歷史和預測數據
按銷售管道分析
網上銷售
零售銷售
機構銷售

第 9 章：全球腸外營養市場分析：依地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：腸外營養公司的競爭格局

腸外營養市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

頂級公司市佔率分析
市場集中度
Baxter

公司概況
公司收入
產品
最新動態

Grifols

公司概況
公司收入
產品
最新動態

公司概況
公司收入
產品
最新動態

Allergan

公司概況
公司收入
產品
最新動態

Otsuka Pharmaceutical Factory Inc.

公司概況
公司收入
產品
最新動態

Actavis Inc.

公司概況
公司收入
產品
最新動態

B. Braun Melsungen AG

公司概況
公司收入
產品
最新動態

Fresenius Kabi AG

公司概況
公司收入
產品
最新動態

Vifor Pharma

公司概況
公司收入
產品
最新動態

Sichuan Kelun Pharmaceutical Co. Ltd.

公司概況
公司收入
產品
最新動態

Pfizer Inc. (Hospira Inc.)

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11213929

The global demand for Parenteral Nutrition Market is presumed to reach the market size of nearly USD 13.41 Billion by 2032 from USD 7.61 Billion in 2023 with a CAGR of 6.49% under the study period 2024-2032.

Parenteral nutrition delivers essential nutrients directly into the bloodstream when a patient's digestive system cannot absorb nutrients from food. Administered intravenously, these nutrition solutions contain a balanced mix of carbohydrates, proteins, fats, vitamins, and minerals tailored to meet the patient's nutritional needs. This specialized form of nutrition support is commonly utilized in critical care settings for patients experiencing severe malnutrition, gastrointestinal disorders, or those undergoing major surgeries.

MARKET DYNAMICS

The factors driving the parenteral nutrition market include the growing incidence of chronic diseases, spurring several surgical procedures, and the expanding geriatric population worldwide. Parenteral nutrition is crucial in managing malnutrition, supporting recovery from surgery, and maintaining health in critically ill patients. Moreover, advancements in medical technology and formulations have spurred the creation of specialized solutions designed to address the nutritional requirements of particular patient groups, such as premature infants, cancer patients, and individuals with gastrointestinal disorders. Additionally, the expanding applications of this nutrition in home healthcare settings and ambulatory care further drive market growth. Furthermore, the growing adoption of total parenteral nutrition (TPN) and peripheral parenteral nutrition (PPN) in hospitals and healthcare facilities and increasing healthcare expenditure and reimbursement policies contribute to the market's expansion. However, regulatory constraints and limited reimbursement options may hinder the market growth in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Parenteral Nutrition. The growth and trends of Parenteral Nutrition industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Parenteral Nutrition market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Nutrient

Carbohydrates
Parenteral Lipid Emulsion
Single Dose Amino Acid Solution
Trace Elements
Vitamins & Minerals

By Stage

Adult
Pediatrics

By Indication

Alzheimer's
Nutrition Deficiency
Cancer Care
Diabetes
Chronic Kidney Diseases
Orphan Diseases
Dysphagia
Pain Management
Malabsorption/GI Disorder/Diarrhea
Others

By Sales Channel

Online Sales
Retail Sales
Institutional Sales

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Parenteral Nutrition market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Parenteral Nutrition market include Baxter, Grifols, S.A., Allergan, Otsuka Pharmaceutical Factory Inc., Actavis Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Vifor Pharma, Sichuan Kelun Pharmaceutical Co. Ltd., Pfizer Inc. (Hospira Inc.). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. PARENTERAL NUTRITION - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Nutrient
- 3.7.2 Market Attractiveness Analysis By Stage
- 3.7.3 Market Attractiveness Analysis By Indication
- 3.7.4 Market Attractiveness Analysis By Sales Channel
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL PARENTERAL NUTRITION MARKET ANALYSIS BY NUTRIENT

5.1. Overview By Nutrient
5.2. Historical and Forecast Data
5.3. Analysis By Nutrient
5.4. Carbohydrates Historic and Forecast Sales By Regions
5.5. Parenteral Lipid Emulsion Historic and Forecast Sales By Regions
5.6. Single Dose Amino Acid Solution Historic and Forecast Sales By Regions
5.7. Trace Elements Historic and Forecast Sales By Regions
5.8. Vitamins & Minerals Historic and Forecast Sales By Regions

6. GLOBAL PARENTERAL NUTRITION MARKET ANALYSIS BY STAGE

6.1. Overview By Stage
6.2. Historical and Forecast Data
6.3. Analysis By Stage
6.4. Adult Historic and Forecast Sales By Regions
6.5. Pediatrics Historic and Forecast Sales By Regions

7. GLOBAL PARENTERAL NUTRITION MARKET ANALYSIS BY INDICATION

7.1. Overview By Indication
7.2. Historical and Forecast Data
7.3. Analysis By Indication
7.4. Alzheimer's Historic and Forecast Sales By Regions
7.5. Nutrition Deficiency Historic and Forecast Sales By Regions
7.6. Cancer Care Historic and Forecast Sales By Regions
7.7. Diabetes Historic and Forecast Sales By Regions
7.8. Chronic Kidney Diseases Historic and Forecast Sales By Regions
7.9. Orphan Diseases Historic and Forecast Sales By Regions
7.10. Dysphagia Historic and Forecast Sales By Regions
7.11. Pain Management Historic and Forecast Sales By Regions
7.12. Malabsorption/GI Disorder/Diarrhea Historic and Forecast Sales By Regions
7.13. Others Historic and Forecast Sales By Regions

8. GLOBAL PARENTERAL NUTRITION MARKET ANALYSIS BY SALES CHANNEL

8.1. Overview By Sales Channel
8.2. Historical and Forecast Data
8.3. Analysis By Sales Channel
8.4. Online Sales Historic and Forecast Sales By Regions
8.5. Retail Sales Historic and Forecast Sales By Regions
8.6. Institutional Sales Historic and Forecast Sales By Regions

9. GLOBAL PARENTERAL NUTRITION MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE PARENTERAL NUTRITION COMPANIES

10.1. Parenteral Nutrition Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF PARENTERAL NUTRITION INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Baxter
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Grifols
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. S.A.
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Allergan
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Otsuka Pharmaceutical Factory Inc.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Actavis Inc.
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. B. Braun Melsungen AG
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Fresenius Kabi AG
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Vifor Pharma
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Sichuan Kelun Pharmaceutical Co. Ltd.
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Pfizer Inc. (Hospira Inc.)
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments